UAE Less than two years into position as CEO of MENA-wide pharma and consumer health player Dar Al Dawa, Khaled Harb looks back on what has already been achieved and the ambitious strategy he has put in place for the short-, medium-, and long-term. Harb also outlines some of the key…
Algeria Key recent investments from Middle Eastern companies into Algerian Pharma. Saudi company Tabuk Pharmaceuticals invests USD 20 million into a plant in Blida (2014) “We arrived in Algeria in 1997 with imports only. Then Tabuk partnered with the Central Pharmacy of Hospitals (PCH) in 2004. We had a renewed…
Algeria Noureddine Issad, general manager of Dar Al Dawa Algeria & Medi Pharma International unveils his ambitions to establish Dar Al Dawa as a major player in the Algerian market through local production of previously untapped product areas and discusses the new position of generics in the Algerian health industry. …
Dar Al Dawa Development & Investment Dar al Dawa is the second biggest Jordanian pharmaceutical manufacturer. What are the main factors that allowed you to be so successful and remain in one of the top positions since the company’s inception in 1974? The key factor has been Jordan. Being poor in natural recourses, Jordan had to…
See our Cookie Privacy Policy Here